VIRMA and posterior cortical atrophy: Remarkably, although differences in VIRMA mRNA expression levels were not statistically significant (one-way ANOVA test), patients with high VIRMA expression endured significantly shorter disease-free survival (Hazard Ratio 2.7, p = 0.0043) (Figure 1C), suggesting clinical significance of VIRMA overexpression in PCa.